• 3 Nov, 2023

Tallac Presents First Clinical Data for TAC-001 at SITC 2023

• 27 Sep, 2023

Tallac Therapeutics Announces Two Abstracts Accepted for Presentation at Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting